Pediatric Lyme Neuroborreliosis (Turkey)

Topics with information and discussion about published studies related to Lyme disease and other tick-borne diseases.
Post Reply
RitaA
Posts: 2768
Joined: Thu 1 Jul 2010 8:33

Pediatric Lyme Neuroborreliosis (Turkey)

Post by RitaA » Sun 14 Aug 2016 16:01

http://www.ncbi.nlm.nih.gov/pubmed/27179572
Neuro Endocrinol Lett. 2016 May 15;37(2):107-113. [Epub ahead of print]

Pediatric Lyme Neuroborreliosis: Different clinical presentations of the same agent; Single center experience.

Celik T1, Celik U2, Kömür M1, Tolunay O3, Yildizdas RD4, Yagci-Kupeli B5, Kücük F3, Eroglu İ3.

Author information

1 Pediatric Neurology, Adana Numune Research and Training Hospital, Turkey.
2 Pediatric Infection, Adana Numune Research and Training Hospital, Turkey.
3 Department of Pediatrics, Adana Numune Research and Training Hospital, Turkey.
4 Pediatric Intensive Care, Çukurova University Faculty of Medicine, Turkey.
5 Pediatric Oncology, Adana Numune Research and Training Hospital, Turkey.

Abstract

OBJECTIVES:

Lyme disease is a vector-associated infectious disease, caused by the agent, spirochete Borrelia burgdorferi. Neurologic findings are observed in approximately 12% of the cases and termed Lyme neuroborreliosis (LNB). Lyme neuroborreliosis may manifest with different clinical neurologic manifestations.

METHODS:

The study was conducted at tertiary training and research hospital. From January 2014 to September 2015, a total of 75 patients diagnosed with encephalitis, ataxia, Guillain Barre Syndrome (GBS), facial paralysis, acute disseminated encephalomyelitis (ADEM), pseudotumorcerebri were evaluated for inclusion to the study. Among these patients whom investigations of B. burgdorferi antibody IgM and/or IgG ELISA and Western Blot (WB) were detected to be positive, were assessed. Epidemiologic data, tick bite histories, duration of symptoms, clinical findings, radiologic findings, treatment durations and prognosis were investigated.

RESULTS:

Totally 7 patients had been treated with the diagnosis of Lyme neuroborreliosis. The mean age was 9.14±4.91 years; duration of symptoms before admission was 8.0±4.50 days; and the duration of antibiotic use was 2.85±0.89 weeks. All patients had received ceftriaxone and intravenous immunoglobulin (IVIG); 3 patients had received plasmapheresis (42.9%) and one patient had received pulse corticosteroid therapy. While the patient with the diagnosis of encephalomyeloneuritis and atypical GBS had partially improved, the other patients were completely cured.

CONCLUSION:

In this article, we report pediatric LNB patients, B. burgdorferi should also be considered in patients with atypical or severe neurologic involvement or a history of tick bite; it is known that the prognosis is good with appropriate and early treatment.

PMID: 27179572
[PubMed - as supplied by publisher]

User avatar
ChronicLyme19
Posts: 564
Joined: Mon 11 Aug 2014 17:42
Location: NY, USA

Re: Pediatric Lyme Neuroborreliosis (Turkey)

Post by ChronicLyme19 » Wed 17 Aug 2016 1:09

"Completely cured", but they were followed for how long?
Half of what you are taught is incorrect, but which half? What if there's another half missing?

Post Reply